Recap of EMUC21: The take-home messagesNovember 30, 2021
Being an event with a multidisciplinary nature, the take-home messages of the 13th European Multidisciplinary Congress on Urological Cancers...0
Another EMUC21 day, another round of best poster award winnersNovember 28, 2021
After three experts from three different fields had won the Best Poster Award – Prostate Cancer on the third...
Personalised approaches to treating GU cancersNovember 27, 2021
Personalised approaches such as the use of circulating tumour DNA (ctDNA) biomarkers and genetic testing is the way to...
EMUC21 shines spotlight on best poster winnersNovember 27, 2021
Demonstrating the multidisciplinary nature of the congress, an oncologist, a radiotherapist, and a urologist each received a Best Poster...
Bladder-preserving strategies unveiled: Topical therapy and TURBTNovember 26, 2021
In order to preserve the quality of life for non-muscle-invasive bladder cancer (NMIBC) patients as much as possible, bladder-preserving...
PSMA PET/CT: Prime tool in staging and treatment monitoringNovember 26, 2021
Plenary Session 1 “Prostate cancer staging in 2021: Where are we, where are we going?” provided delegates with expert...
Strengths and limitations of PSMA PET: When to use it (and when not to)November 26, 2021
The prostate-specific membrane antigen positron emission tomography (PSMA PET) scan is the (relatively) new kid on the block in...
Definitive: EMUC21 is coming to Athens!September 24, 2021
New crucial updates in GU cancer prevention, diagnosis and management Relive and enjoy the congress experience, meet and connect...
Radioligand therapy: multidisciplinary collaboration for health system readinessSeptember 13, 2021
By the European Society for Medical Oncology (ESMO) team Join the EMUC21 session ‘Radioligand therapy: multidisciplinary collaboration for health...